Australian Rotavirus Surveillance Program: Annual Report, 2016
DOI:
https://doi.org/10.33321/cdi.2017.41.48Keywords:
rotavirus, gastroenteritis, genotypes, disease surveillance, Australia, vaccine, RotaTeq, RotarixAbstract
This report from the Australian Rotavirus Surveillance Program (ARSP) and collaborating laboratories Australia-wide, describes the rotavirus genotypes identified in children and adults with acute gastroenteritis during the period 1 January to 31 December 2016. During this period, 949 faecal specimens were referred for rotavirus G and P genotype analysis, of which 230 were confirmed as positive for wildtype rotavirus, and 184 were identified as rotavirus vaccine-like. Genotype analysis of the 230 samples from both children and adults revealed that G2P[4] was the dominant genotype in this reporting period nationally, identified in 29% of samples, followed by equine-like G3P[8] and G12P[8] (19% and 15% respectively). Genotype distribution remained distinct between States using RotaTeq® and Rotarix® vaccines. In RotaTeq® States, G12P[8] strains were more common, while G2P[4] and equine-like G3P[8] genotypes were more common in Rotarix® States and Territories. This report highlights the continued dominance of G12P[8] strains in RotaTeq® States and co-dominance of G2P[4] and equine-like G3P[8] in States and Territories using Rotarix®.
Downloads
References
Estes M, Kapikian A. Rotaviruses. In: Fields virology. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007. vol 1 p. 1917-74.
Moussa A, Fredj MBH, BenHamida-Rebaï M, Fodha I, Boujaafar N, Trabelsi A. Phylogenetic analysis of partial VP7 gene of the emerging human group A rotavirus G12 strains circulating in Tunisia. Journal of Medical Microbiology 2017;66(2):112-8.
Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. Clin Infect Dis 2016;62 Suppl 2:S96-s105.
Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12(2):304-6.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23-33.
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354(1):11-22.
PATH. Rotavirus vaccine access and delivery. Available from: http://sites.path.org/rotavirusvaccine/
Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011;30(1 Suppl):S25-9.
Carlin J CP, Masendycz P, Bugg H, Bishop R, Barnes G. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust 1998;169(5):252-6.
Macartney K, Dey A, Wang H, Quinn H, Wood N, McIntyre P. Ten years of rotavirus immunisation in Australia: sustained benefits outweigh vaccine-associated risks (Poster). In: 12th International Rotavirus Symposium; Melbourne, Australia; 2016.
Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R, et al. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine 2017;35(2):345-52.
Kirkwood CD, Boniface K, Bogdanovic-Sakran N, Masendycz P, Barnes GL, Bishop RF. Rotavirus strain surveillance--an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine 2009;27 Suppl 5:F102-7.
Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30(6):1365-73.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28(2):276-82.
Itturiza-Gomara M, Cubitt D, Desselberger U, Gray J. Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol 2001;39(10):3796-8.
Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, et al. New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol 2008;42(4):368-73.
Banerjee I, Ramani S, Primrose B, Iturriza-Gomara M, Gray JJ, Brown DW, et al. Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India. J Med Virol 2007;79(9):1413-21.
Maes P, Matthijnssens J, Rahman M, Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol 2009;9:238.
Donato CM, Ch’ng LS, Boniface KF, Crawford NW, Buttery JP, Lyon M, et al. Identification of Strains of RotaTeq® Rotavirus Vaccine in Infants With Gastroenteritis Following Routine Vaccination. Journal of Infectious Diseases 2012;206(3):377-83.
Elschner M, Prudlo J, Hotzel H, Otto P, Sachse K. Nested reverse transcriptase-polymerase chain reaction for the detection of group A rotaviruses. J Vet Med B Infect Dis Vet Public Health 2002;49(2):77-81.
Schepetiuk S, Kirkwood C, Roczo-Farkas S, Higgins G. Prevalence of RotaTeq® vaccine viruses in routine faecal specimens. Journal of Clinical Virology 2015;70:S31-S2.
Cowley D, Donato CM, Roczo-Farkas S, Kirkwood CD. Emergence of a novel equine-like G3P[8] inter-genogroup reassortant rotavirus strain associated with gastroenteritis in Australian children. J Gen Virol 2016;97(2):403-10.
Roczo-Farkas S, Kirkwood CD, Bines JE. Australian Rotavirus Surveillance Program annual report, 2015. Commun Dis Intell Q Rep 2016;40(4):E527-e38.
McAtee CL, Webman R, Gilman RH, Mejia C, Bern C, Apaza S, et al. Burden of Norovirus and Rotavirus in Children after Rotavirus Vaccine Introduction, Cochabamba, Bolivia. The American Journal of Tropical Medicine and Hygiene 2016;94(1):212-7.
Gastañaduy PA, Contreras-Roldán I, Bernart C, López B, Benoit SR, Xuya M, et al. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala. Clinical Infectious Diseases 2016;62(suppl_2):S121-S6.
Pitzer VE, Bilcke J, Heylen E, Crawford FW, Callens M, De Smet F, et al. Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium? Sci Rep 2015;5:18585.
Matthijnssens J, Zeller M, Heylen E, De Coster S, Vercauteren J, Braeckman T, et al. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin Microbiol Infect 2014;20(10):O702-10.
Donato CM, Cowley D, Donker NC, Bogdanovic-Sakran N, Snelling TL, Kirkwood CD. Characterization of G2P[4] rotavirus strains causing outbreaks of gastroenteritis in the Northern Territory, Australia, in 1999, 2004 and 2009. Infect Genet Evol 2014;28:434-45.
Leshem E, Lopman B, Glass R, Gentsch J, Bányai K, Parashar U, et al. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. The Lancet Infectious Diseases 2014;14(9):847-56.
Santos VS, Marques DP, Martins-Filho PRS, Cuevas LE, Gurgel RQ. Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis. Infectious Diseases of Poverty 2016;5:83.
Ye S, Whiley DM, Ware RS, Sloots TP, Kirkwood CD, Grimwood K, et al. Detection of viruses in weekly stool specimens collected during the first 2 years of life: A pilot study of five healthy Australian infants in the rotavirus vaccine era. J Med Virol 2017;89(5):917-21.
Tate JE, Mijatovic-Rustempasic S, Tam KI, Lyde FC, Payne DC, Szilagyi P, et al. Comparison of 2 Assays for Diagnosing Rotavirus and Evaluating Vaccine Effectiveness in Children with Gastroenteritis. Emerging Infectious Diseases 2013;19(8):1245-52.
Ghosh N, Malik FA, Daver RG, Vanichanan J, Okhuysen PC. Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center: a 10-year retrospective study. Infect Dis (Lond) 2017;49(2):113-9.
Bezerra DAM, Guerra SFS, Serra ACS, Fecury PCMS, Bandeira RS, Penha ET, et al. Analysis of a genotype G3P[9] rotavirus a strain that shows evidence of multiple reassortment events between animal and human rotaviruses. Journal of Medical Virology 2017;89(6):974-81.
Dong H, Qian Y, Nong Y, Zhang Y, Mo Z, Li R. [Genomic Characterization of an Unusual Human G3P[3] Rotavirus with Multiple Cross-species Reassortment]. Bing Du Xue Bao 2016;32(2):129-40.
Jeong S, Than VT, Lim I, Kim W. Whole-genome analysis of a rare human Korean G3P rotavirus strain suggests a complex evolutionary origin potentially involving reassortment events between feline and bovine rotaviruses. PLoS One 2014;9(5):e97127.
Theamboonlers A, Maiklang O, Thongmee T, Chieochansin T, Vuthitanachot V, Poovorawan Y. Complete genome analysis of a rare human G3P[9] rotavirus posing as an AU-1 like strain. Springerplus 2013;2:569.
Grant L, Esona M, Gentsch J, Watt J, Reid R, Weatherholtz R, et al. Detection of G3P[3] and G3P[9] rotavirus strains in American Indian children with evidence of gene reassortment between human and animal rotaviruses. J Med Virol 2011;83(7):1288-99.
Luchs A, Timenetsky MdCST. Group A rotavirus gastroenteritis: post-vaccine era, genotypes and zoonotic transmission. Einstein 2016;14(2):278-87.
Martella V, Banyai K, Matthijnssens J, Buonavoglia C, Ciarlet M. Zoonotic aspects of rotaviruses. Vet Microbiol 2010;140(3-4):246-55.
Patton JT. Rotavirus diversity and evolution in the post-vaccine world. Discov Med 2012;13(68):85-97.
Rahman M, Matthijnssens J, Yang X, Delbeke T, Arijs I, Taniguchi K, et al. Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol 2007;81(5):2382-90.
WA Notifiable Infectious Disease Database (WANIDD) CDCD, Department of Health WA. Notifiable Infectious Disease Reports, WA Department of Health - Rotavirus notifications in Western Australia. 2017 [cited 2017 4/5/2017]; Available from: http://www.public.health.wa.gov.au/3/1567/3/rotavirus.pm
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2017 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
